These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6687814)

  • 1. Field desorption mass spectrometric characterization of thiol conjugates related to the oxidative metabolism of the anticancer drug 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
    Gaudich K; Przybylski M
    Biomed Mass Spectrom; 1983 Apr; 10(4):292-9. PubMed ID: 6687814
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of conjugation and cleavage products in the thiolytic metabolism of the anticancer drug 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Przybylski M; Cysyk RL; Shoemaker D; Adamson RH
    Biomed Mass Spectrom; 1981 Oct; 8(10):485-91. PubMed ID: 6895335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.
    Przybylski M
    Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 4'-(9-acridinylamino)methanesulfon-m-anisidide by rat liver microsomes.
    Shoemaker DD; Cysyk RL; Gormley PE; DeSouza JJ; Malspeis L
    Cancer Res; 1984 May; 44(5):1939-45. PubMed ID: 6546898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the principal biliary metabolite of 4'-(9-acridinylamino)methanesulfon-m-anisidide in rats.
    Shoemaker DD; Cysyk RL; Padmanabhan S; Bhat HB; Malspeis L
    Drug Metab Dispos; 1982; 10(1):35-9. PubMed ID: 6124380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pharmacokinetics of a new acridine derivative, 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992).
    Hall SW; Friedman J; Legha SS; Benjamin RS; Gutterman JU; Loo TL
    Cancer Res; 1983 Jul; 43(7):3422-6. PubMed ID: 6687834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary excretion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in rats: effects of pretreatment with diethyl maleate, phenobarbital, and metyrapone.
    Shoemaker DD; Gormley PE; Cysyk RL
    Drug Metab Dispos; 1980; 8(6):467-8. PubMed ID: 6109618
    [No Abstract]   [Full Text] [Related]  

  • 8. The characterization of two biliary glutathione conjugates of amsacrine using liquid secondary ion mass spectrometry.
    Robertson IG; Palmer BD; Shaw GJ
    Biol Mass Spectrom; 1993 Nov; 22(11):661-5. PubMed ID: 8251552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of the thiol adducts of 4'-(9-acridinylamino)methanesulfon-m-anisidide and their binding to deoxyribonucleic acid.
    Wong A; Huang CH; Hwang SM; Prestayko AW; Crooke ST
    Biochem Pharmacol; 1986 May; 35(10):1655-62. PubMed ID: 3754750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the antitumor drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines with nucleic acids.
    Wilson WR; Baguley BC; Wakelin LP; Waring MJ
    Mol Pharmacol; 1981 Sep; 20(2):404-14. PubMed ID: 6170872
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of viral growth by the antitumor drug 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA).
    Drake S; Furlong NB; Nelson JA
    Biochem Pharmacol; 1983 Sep; 32(17):2615-8. PubMed ID: 6688528
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Zwelling LA; Kerrigan D; Michaels S
    Cancer Res; 1982 Jul; 42(7):2687-91. PubMed ID: 6896293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.
    Ahmann FR; Meyskens FL; Moon TE; Durie BG; Salmon SE
    Cancer Res; 1982 Nov; 42(11):4495-8. PubMed ID: 6897012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
    Arlin ZA; Sklaroff RB; Gee TS; Kempin SJ; Howard J; Clarkson BD; Young CW
    Cancer Res; 1980 Sep; 40(9):3304-6. PubMed ID: 6933002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
    Currie VE; Howard J; Wittes R
    Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma.
    Warrell RP; Straus DJ; Young CW
    Cancer Treat Rep; 1980; 64(10-11):1157-8. PubMed ID: 6893952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-cycle-stage specificity of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and interaction with ionizing radiation in mammalian cell cultures.
    Wilson WR; Whitmore GF
    Radiat Res; 1981 Jul; 87(1):121-36. PubMed ID: 7019954
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of the glutathione metaboloma peptides by energy-resolved mass spectrometry as a tool to investigate into the interference of toxic heavy metals with their metabolic processes.
    Rubino FM; Pitton M; Brambilla G; Colombi A
    J Mass Spectrom; 2006 Dec; 41(12):1578-93. PubMed ID: 17136764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
    Casper ES; Gralla RJ; Kelsen DP; Natale RB; Sordillo P; Houghton A
    Cancer Treat Rep; 1980; 64(2-3):345-7. PubMed ID: 6893294
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.
    Schneider RJ; Woodcock TM; Yagoda A
    Cancer Treat Rep; 1980 Jan; 64(1):183-5. PubMed ID: 6892892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.